---
created: '2026-02-08T19:45:44.544744Z'
description: Measuring ApoB levels is important because it provides a direct count
  of plaque-forming cholesterol particles in the blood. It is powerful indicator of
  harmful particles that drive cardiovascular risk and contribute to metabolic dysfunction.
dg-home: false
dg-publish: true
gardenUsername: dev_admin
permalink: /garden/dev_admin/labtest/apolipoprotein-b-apob/
slug: apolipoprotein-b-apob
tags:
- labtest
title: apolipoprotein_b_apob
type: labtest
updated: '2026-02-08T19:45:44.544744Z'
---

# Apolipoprotein B (ApoB)

## Overview
Measuring ApoB levels is important because it provides a direct count of plaque-forming cholesterol particles in the blood. It is powerful indicator of harmful particles that drive cardiovascular risk and contribute to metabolic dysfunction.

**Evidence Level:** ⭐⭐⭐ (3/5)

## Test Information

| Property | Value |
|----------|-------|
| **Category** | Blood Panel |
| **Subcategory** | Lipid Panel || **Test Type** | Standard |
| **Sample Type** | Blood |
| **Collection Method** | Venipuncture |
| **Turnaround Time** | 3-7 days || **Price Range** | $null-$null || **HSA Eligible** | ✅ Yes || **FSA Eligible** | ✅ Yes |




## Recommended For

### Supplement Monitoring
No specific supplement monitoring recommendations.

### Conditions
Useful for monitoring or diagnosing:

- [[Cardiovascular Disease]]
- [[Atherosclerosis]]
- [[Dyslipidemia]]
- [[Metabolic Syndrome]]
- [[Type 2 Diabetes Or Insulin Resistance]]

## Reference Ranges

Reference ranges vary by laboratory and testing method. Consult your healthcare provider for interpretation.

<!-- NEO4J_CONTENT_START -->
## Relationships
### Related
- → [[Metabolic_Syndrome]] (entity)
```yaml
last_modified: '2026-01-26T06:48:08.401813'
source: obsidian
```
- → [[Type_2_Diabetes_Or_Insulin_Resistance]] (entity)
```yaml
last_modified: '2026-01-26T06:48:08.401813'
source: obsidian
```
- → [[Cardiovascular_Disease]] (entity)
```yaml
last_modified: '2026-01-26T06:48:08.401813'
source: obsidian
```
- → [[Dyslipidemia]] (entity)
```yaml
last_modified: '2026-01-26T07:07:50.100619'
source: obsidian
```
- → [[Atherosclerosis]] (entity)
```yaml
last_modified: '2026-01-26T07:07:50.100619'
source: obsidian
```
- → [[Type_2_Diabetes_Or_Insulin_Resistance]] (entity)
```yaml
last_modified: '2026-01-26T07:07:50.100619'
source: obsidian
```
- → [[Cardiovascular_Disease]] (condition)
```yaml
last_modified: '2026-01-26T07:07:50.100619'
source: obsidian
```
- → [[Metabolic_Syndrome]] (condition)
```yaml
last_modified: '2026-01-26T07:07:50.100619'
source: obsidian
```
- ← [[genetic_heart_risks]] (labtestpanel)
```yaml
last_modified: '2026-01-26T07:08:04.533403'
source: obsidian
```
- ← [[extended_heart_metabolic]] (labtestpanel)
```yaml
last_modified: '2026-01-26T07:08:02.868961'
source: obsidian
```
- → [[extended_heart_metabolic]] (labtestpanel)
```yaml
last_modified: '2026-01-26T06:48:08.401813'
source: obsidian
```
- → [[genetic_heart_risks]] (labtestpanel)
```yaml
last_modified: '2026-01-26T06:48:08.401813'
source: obsidian
```
- ← [[Metabolic_Syndrome]] (condition)
```yaml
last_modified: '2026-01-26T07:07:32.678592'
source: obsidian
```
- ← [[Cardiovascular_Disease]] (condition)
```yaml
last_modified: '2026-01-26T07:07:24.806764'
source: obsidian
```

### May Detect
- → [[Metabolic_Syndrome]] (condition)
```yaml
confidence: suggested
created_at: '2026-01-18T16:02:36.677740'
source: function-health
```
- → [[Cardiovascular_Disease]] (condition)
```yaml
confidence: suggested
created_at: '2026-01-18T16:02:36.677740'
source: function-health
```

### Included In
- → [[genetic_heart_risks]] (labtestpanel)
- → [[extended_heart_metabolic]] (labtestpanel)
<!-- NEO4J_CONTENT_END -->
## Relationships
No relationships found.

## Notes

- Results should be interpreted by a qualified healthcare provider
- Reference ranges may vary by laboratory
- Individual factors (age, sex, health status) affect interpretation

---
*Last Updated: 2026-01-19T09:32:15.764128*